Influence of treatments on cell adhesion molecules in patients with systemic lupus erythematosus and rheumatoid arthritis: a review.
Lorena Flor da Rosa Franchi SantosNeide Tomimura CostaMichael MaesAndréa Name Colado SimãoIsaias DichiPublished in: Inflammopharmacology (2019)
It is concluded that the CAM biomarkers may reflect disease activity and the response to treatment in SLE and RA patients.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- ankylosing spondylitis
- rheumatoid arthritis patients
- cell adhesion
- juvenile idiopathic arthritis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- interstitial lung disease
- prognostic factors
- combination therapy